149 related articles for article (PubMed ID: 33014785)
1. Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer.
Huang H; Li J; Shen J; Lin L; Wu X; Xiang S; Li Y; Xu Y; Zhao Q; Zhao Y; Kaboli PJ; Li M; Li X; Wang W; Wen Q; Xiao Z
Front Oncol; 2020; 10():1474. PubMed ID: 33014785
[TBL] [Abstract][Full Text] [Related]
2. ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.
Oprea-Lager DE; Bijnsdorp IV; VAN Moorselaar RJ; VAN DEN Eertwegh AJ; Hoekstra OS; Geldof AA
Anticancer Res; 2013 Feb; 33(2):387-91. PubMed ID: 23393328
[TBL] [Abstract][Full Text] [Related]
3. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
4. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-related receptor α expression and function are associated with vascular endothelial growth factor in human cervical cancer.
Mori T; Sawada M; Kuroboshi H; Tatsumi H; Katsuyama M; Iwasaku K; Kitawaki J
Int J Gynecol Cancer; 2011 May; 21(4):609-15. PubMed ID: 21546870
[TBL] [Abstract][Full Text] [Related]
6. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
8. Function of estrogen-related receptor alpha in human endometrial cancer.
Watanabe A; Kinoshita Y; Hosokawa K; Mori T; Yamaguchi T; Honjo H
J Clin Endocrinol Metab; 2006 Apr; 91(4):1573-7. PubMed ID: 16464951
[TBL] [Abstract][Full Text] [Related]
9. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
10. ERRα promotes pancreatic cancer progression by enhancing the transcription of PAI1 and activating the MEK/ERK pathway.
Liu SL; Wu XS; Li FN; Yao WY; Wu ZY; Dong P; Wang XF; Gong W
Am J Cancer Res; 2020; 10(11):3622-3643. PubMed ID: 33294258
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.
Stein RA; Chang CY; Kazmin DA; Way J; Schroeder T; Wergin M; Dewhirst MW; McDonnell DP
Cancer Res; 2008 Nov; 68(21):8805-12. PubMed ID: 18974123
[TBL] [Abstract][Full Text] [Related]
12. The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
Lundon DJ; Boland A; Prencipe M; Hurley G; O'Neill A; Kay E; Aherne ST; Doolan P; Madden SF; Clynes M; Morrissey C; Fitzpatrick JM; Watson RW
BMC Cancer; 2017 Mar; 17(1):163. PubMed ID: 28249598
[TBL] [Abstract][Full Text] [Related]
13. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q
Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer.
Matsushima H; Mori T; Ito F; Yamamoto T; Akiyama M; Kokabu T; Yoriki K; Umemura S; Akashi K; Kitawaki J
Oncotarget; 2016 Jun; 7(23):34131-48. PubMed ID: 27153547
[TBL] [Abstract][Full Text] [Related]
17. ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism.
Berman AY; Manna S; Schwartz NS; Katz YE; Sun Y; Behrmann CA; Yu JJ; Plas DR; Alayev A; Holz MK
Signal Transduct Target Ther; 2017; 2():17035-. PubMed ID: 28890840
[TBL] [Abstract][Full Text] [Related]
18. A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells.
Senga S; Kawaguchi K; Kobayashi N; Ando A; Fujii H
Oncotarget; 2018 Aug; 9(60):31753-31770. PubMed ID: 30167092
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a selective inverse agonist for estrogen related receptor α as a potential agent for breast cancer.
Zhang L; Liu P; Chen H; Li Q; Chen L; Qi H; Shi X; Du Y
Eur J Pharmacol; 2016 Oct; 789():439-448. PubMed ID: 27498368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
